EAPC Premium Access

Discussion - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Topic: Diabetes and the Heart
Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

Congress Session

About the speakers

Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))
35 presentations
0 follower

Professor Richard Hobbs

Oxford (United Kingdom of Great Britain & Northern Ireland)
8 presentations
0 follower

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)
32 presentations
0 follower

4 more presentations in this session

Introduction - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Speaker: Professor D. Grobbee (Utrecht, NL)

Thumbnail

The cardiovascular challenge for primary care in diabetes.

Speaker: Professor R. Hobbs (Oxford, GB)

Thumbnail

Diabetes: how to reduce risk from a cardiovascular perspective?

Speaker: Professor D. Grobbee (Utrecht, NL)

Thumbnail

Practical management of cardiovascular risk: lessons from latest diabetes trials.

Speaker: Professor L. Ryden (Stockholm, SE)

Thumbnail

Access the full session

Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Speakers: Professor D. Grobbee, Professor R. Hobbs, Professor L. Ryden, Professor D. Grobbee, Professor R. Hobbs...
Thumbnail

About the event

Image

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk